Trends and demographic patterns in biologic and corticosteroid prescriptions for inflammatory bowel disease: findings from electronic medical records, 2011–2020
Fang Xu, Yong Liu, Kurt Greenlund, Susan Carlson
DOI: 10.1136/jim-2022-002486 Published 1 December 2022
Fang Xu
Division of Population Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
Yong Liu
Division of Population Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
Kurt Greenlund
Division of Population Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
Susan Carlson
Division of Population Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
Submit a Response to This Article
No eLetters have been published for this article.
Trends and demographic patterns in biologic and corticosteroid prescriptions for inflammatory bowel disease: findings from electronic medical records, 2011–2020
Fang Xu, Yong Liu, Kurt Greenlund, Susan Carlson
Journal of Investigative Medicine Dec 2022, 70 (8) 1771-1776; DOI: 10.1136/jim-2022-002486
Trends and demographic patterns in biologic and corticosteroid prescriptions for inflammatory bowel disease: findings from electronic medical records, 2011–2020
Fang Xu, Yong Liu, Kurt Greenlund, Susan Carlson
Journal of Investigative Medicine Dec 2022, 70 (8) 1771-1776; DOI: 10.1136/jim-2022-002486
Trends and demographic patterns in biologic and corticosteroid prescriptions for inflammatory bowel disease: findings from electronic medical records, 2011–2020
Fang Xu, Yong Liu, Kurt Greenlund, Susan Carlson
Journal of Investigative Medicine Dec 2022, 70 (8) 1771-1776; DOI: 10.1136/jim-2022-002486